logo
Select company
Select metric
$ 6.66MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
62
Sector
71
Industry
74
History
80
$ 4.15Close
$ 3.28 - $ 45.6 52-Week Range
Ticker Information

Ticker

CDIO

Company Name

CARDIO DIAGNOSTICS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARDIO DIAGNOSTICS HOLDINGS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CDIO - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 6.66M
3/31/2025$ 8.13M
12/31/2024$ 6.54M
9/30/2024$ -1.65M
6/30/2024$ -3.73M
3/31/2024$ -5.14M
12/31/2023$ -2.83M
9/30/2023$ -5.33M
6/30/2023$ -4.62M
12/31/2022$ 3.6M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARDIO DIAGNOSTICS HOLDINGS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 9.67M.
  • Over the past 5 years, CARDIO DIAGNOSTICS HOLDINGS INC's average CF - Chg. Cash has been $ 1.03M.
  • The median CF - Chg. Cash for CARDIO DIAGNOSTICS HOLDINGS INC during this period was $ -1.65M
  • CARDIO DIAGNOSTICS HOLDINGS INC reached its highest CF - Chg. Cash over the past 5 years at $ 9.67M.
  • The lowest CF - Chg. Cash recorded by CARDIO DIAGNOSTICS HOLDINGS INC in the same timeframe $ -5.33M

CARDIO DIAGNOSTICS HOLDINGS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
ADTX : ADITXT INC $ 232.46KIBO : IMPACT BIOMEDICAL INC $ 622KCELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ -927.36KACXP : ACURX PHARMACEUTICALS INC $ -296.73KAPVO : APTEVO THERAPEUTICS INC $ 1.34MPMCB : PHARMACYTE BIOTECH INC $ -19.46MGNPX : GENPREX INC $ -1.11MALZN : ALZAMEND NEURO INC $ 4.43MPALI : PALISADE BIO INC $ -5.94MTCRT : ALAUNOS THERAPEUTICS INC $ 415K

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

CDIO - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -5.33M

Minimum

Sep 30, 2023

$ 9.67M

Maximum

Jun 30, 2022

$ 1.03M

Average

$ -1.65M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 45.08M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 138.09M
average$ 1.18M
median$ 116.12K
std$ 45.08M